Item Type | Name |
Academic Article
|
Mechanisms of FUS1/TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects.
|
Academic Article
|
Fibulin-2 is a driver of malignant progression in lung adenocarcinoma.
|
Academic Article
|
Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model.
|
Academic Article
|
Activating enhancer-binding protein-2? nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection.
|
Academic Article
|
Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer.
|
Concept
|
Immunohistochemistry
|
Academic Article
|
Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.
|
Academic Article
|
Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
|
Academic Article
|
Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis.
|
Academic Article
|
Sox10-positive sustentacular cells in neuroendocrine carcinoma of the lung.
|
Academic Article
|
Oncocytic neuroendocrine tumors of the lung: histopathologic spectrum and immunohistochemical analysis of 15 cases.
|
Academic Article
|
Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas.
|
Academic Article
|
Clinicopathological and immunohistochemical analysis of spindle-cell carcinoid tumour of the lung.
|
Academic Article
|
Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1.
|
Academic Article
|
Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases.
|
Academic Article
|
Primary mediastinal seminomas: a comprehensive immunohistochemical study with a focus on novel markers.
|
Academic Article
|
[Gallbladder cancer: immunohistochemical expression of CA-19-9, epithelial membrane antigen, dupan-2 and carcinoembryonic antigen].
|
Academic Article
|
Identification of novel cellular targets in biliary tract cancers using global gene expression technology.
|
Academic Article
|
Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
|
Academic Article
|
An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung.
|
Academic Article
|
Proliferating cell nuclear antigen in gallbladder carcinoma.
|
Academic Article
|
p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study.
|
Academic Article
|
[Epidermoid carcinoma of the cervix uteri: molecular abnormalities of p53 and rb genes].
|
Academic Article
|
Comparison of features of human breast cancer cell lines and their corresponding tumors.
|
Academic Article
|
K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix.
|
Academic Article
|
Bronchioalveolar cell carcinoma: radiologic appearance and dilemmas in the assessment of response.
|
Academic Article
|
Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry.
|
Academic Article
|
Molecular biology, genomics, and proteomics in bronchioloalveolar carcinoma.
|
Academic Article
|
Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
|
Academic Article
|
Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer.
|
Academic Article
|
Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma.
|
Academic Article
|
Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation.
|
Academic Article
|
Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence.
|
Academic Article
|
Identification of a subset of human non-small cell lung cancer patients with high PI3K? and low PTEN expression, more prevalent in squamous cell carcinoma.
|
Academic Article
|
Radiation-enhanced lung cancer progression in a transgenic mouse model of lung cancer is predictive of outcomes in human lung and breast cancer.
|
Academic Article
|
[Gastric cancer: epidermal growth factor and epidermal growth factor receptor].
|
Academic Article
|
[Immunohistochemical expression of the carcinoembryonic antigen in gallbladder cancer].
|
Academic Article
|
[Immunohistochemical expression of epidermal growth factor receptor (EGFR) in epidermoid carcinoma of the cervix uteri and its precursor lesions].
|
Academic Article
|
Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
|
Academic Article
|
Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.
|
Academic Article
|
A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer.
|
Academic Article
|
Mismatch repair expression in testicular cancer predicts recurrence and survival.
|
Academic Article
|
Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development.
|
Academic Article
|
Expression of interleukin-1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesions.
|
Academic Article
|
Biological activity of celecoxib in the bronchial epithelium of current and former smokers.
|
Academic Article
|
Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers.
|
Academic Article
|
A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis.
|
Academic Article
|
The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival.
|
Academic Article
|
TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients.
|
Academic Article
|
[Proliferating cell nuclear antigen in cervical cancer and precursor lesions].
|
Academic Article
|
DNA analysis at p53 locus in adenoid cystic carcinoma: comparison of molecular study and p53 immunostaining.
|
Academic Article
|
Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
|
Academic Article
|
Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer.
|
Academic Article
|
Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patients.
|
Academic Article
|
Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.
|
Academic Article
|
Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling.
|
Academic Article
|
Expression and regulation of scavenger receptor class B type I (SR-BI) in gall bladder epithelium.
|
Academic Article
|
[Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
|
Academic Article
|
Aromatase expression predicts survival in women with early-stage non small cell lung cancer.
|
Academic Article
|
Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer.
|
Academic Article
|
Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma.
|
Academic Article
|
Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications.
|
Academic Article
|
Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samples.
|
Academic Article
|
Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver study.
|
Academic Article
|
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.
|
Academic Article
|
Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?
|
Academic Article
|
Multiplatform-based molecular subtypes of non-small-cell lung cancer.
|
Academic Article
|
Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samples
|
Academic Article
|
Primary Mediastinal Yolk Sac Tumors
|
Academic Article
|
Mig-6 deficiency cooperates with oncogenic Kras to promote mouse lung tumorigenesis.
|
Academic Article
|
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.
|
Academic Article
|
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
|
Academic Article
|
Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity.
|
Academic Article
|
Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases.
|
Academic Article
|
Primary Mediastinal Yolk Sac Tumors: An Immunohistochemical Analysis of 14 Cases.
|
Academic Article
|
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients.
|
Academic Article
|
Evidence against a role for jaagsiekte sheep retrovirus in human lung cancer.
|
Academic Article
|
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function.
|
Academic Article
|
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
|
Academic Article
|
Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
|
Academic Article
|
A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer.
|
Academic Article
|
Expression of PD-1 and PD-L1 in thymic epithelial neoplasms.
|
Academic Article
|
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer.
|
Academic Article
|
Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
|
Academic Article
|
Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues.
|
Academic Article
|
Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors.
|
Academic Article
|
Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer.
|
Academic Article
|
B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density.
|
Academic Article
|
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients.
|
Academic Article
|
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.
|
Academic Article
|
Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1 expression findings in triple-negative breast cancer.
|
Academic Article
|
Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer.
|
Academic Article
|
Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy.
|
Academic Article
|
A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma.
|
Academic Article
|
Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancer.
|
Academic Article
|
High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer.
|
Academic Article
|
Round Robin Evaluation of MET Protein Expression in Lung Adenocarcinomas Improves Interobserver Concordance.
|
Academic Article
|
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee.
|
Academic Article
|
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation.
|
Academic Article
|
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
|
Academic Article
|
Sarcomatoid Mesothelioma: A CDKN2A molecular analysis of 53 cases with immunohistochemical correlation with BAP1.
|
Academic Article
|
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity.
|
Academic Article
|
PD-L1 as a biomarker of response to immune-checkpoint inhibitors.
|
Academic Article
|
Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1).
|
Academic Article
|
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.
|
Academic Article
|
PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.
|
Academic Article
|
Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues.
|
Academic Article
|
Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) Study.
|
Academic Article
|
The immunogenomic landscape of resected intrahepatic cholangiocarcinoma.
|
Academic Article
|
Impact of Region-of-Interest Size on Immune Profiling Using Multiplex Immunofluorescence Tyramide Signal Amplification for Paraffin-Embedded Tumor Tissues.
|
Academic Article
|
Deep Learning-Based H-Score Quantification of Immunohistochemistry-Stained Images.
|